Royal Bank of Canada raises target for HCA Healthcare stock to USD 496.00

Published on 10/19/2026 at 09:33 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Second-quarter revenue rose 8.70 percent to USD 20.23 billion. HCA Healthcare stock costs EUR 407.70 on October 19, 2026 at Lang & Schwarz.

Analyst revisions and earnings calendar

Royal Bank of Canada raised its HCA Healthcare target from USD 435.00 to USD 496.00 on October 7, 2026.
Second-quarter revenue reached USD 20.23 billion, up 8.70 percent year over year.
HCA Healthcare stock trades at EUR 407.70 at 9:30 a.m. CEST at Lang & Schwarz on October 19, 2026.

Fotorealistisches Krankenhaus-Außengebäude mit Ambulanzen am Haupteingang bei Sonnenuntergang — HCA Healthcare US40412C1018 zeigt einen modernen Krankenhaus Campus mit Notaufnahme bei goldenem Abendlicht, Illustration mit AI erstellt.

HCA Healthcare (ISIN US40412C1018) generated USD 20.23 billion in second-quarter revenue, up 8.70 percent year over year, according to MarketBeat. The latest analyst change in the coverage reviewed was Royal Bank of Canada's October 7, 2026 increase of its target from USD 435.00 to USD 496.00.

Three dates shape the story

On July 24, 2026, HCA Healthcare reported second-quarter revenue of USD 20.23 billion and earnings per share of USD 7.59, above the USD 7.56 consensus, according to MarketBeat. On October 7, 2026, Royal Bank of Canada raised its target from USD 435.00 to USD 496.00 and assigned an Outperform rating, the same source reported. On October 27, 2026, HCA Healthcare is scheduled to hold its third-quarter earnings call, according to the company's investor release.

What supports the target?

The second-quarter revenue comparison is the clearest operating support for the higher target. Revenue exceeded the USD 19.76 billion analyst estimate by USD 470.00 million, while earnings per share beat the USD 7.56 consensus by USD 0.03, according to MarketBeat. The counterweight is reimbursement and payer-mix pressure. Cantor Fitzgerald cited the expected expiration of USD 520.00 million in non-recurring Florida Directed Payment Program funds and projected second-half admissions growth of 1.90 percent, versus 1.70 percent consensus, in an October 2, 2026 note reported by Investing.com.

Next reporting date is October 27

HCA Healthcare's next dated investor event is the third-quarter 2026 earnings call on October 27, 2026, at 10:00 a.m. Eastern time. The company announced the event in a September 30, 2026 release published on its investor website. That date gives investors the next scheduled checkpoint for revenue, earnings per share and the full-year outlook.

Euro quote stays the market marker

HCA Healthcare was trading at EUR 407.70 at Lang & Schwarz on October 19, 2026 at 9:30 a.m. CEST. The primary listing is NYSE, where the stock was last quoted at USD 458.84 on October 16, 2026 at 4:00 p.m. Eastern time. The 52-week range was USD 353.99 to USD 556.52, and market capitalization was USD 99.3 billion as of October 16, 2026.

The further course of trading is shown by the continuously updated real-time quote of HCA Healthcare stock.